Tauopathies are a group of progressive neurological diseases caused by the accumulation of misfolded tau proteins in the brain. These diseases, which include Alzheimer’s disease and some forms of frontotemporal dementia, are characterized by neuron death and subsequent cognitive and physical decline. Tauopathies are difficult to diagnose and have no known cure; current treatments are mainly palliative. Tau proteins are a class of proteins found in the cytoskeleton of neurons, and are involved in the maintenance of neuronal structure and communication. In healthy cells, tau proteins ensure that the microtubules in a neuron remain stable. In individuals with tauopathies, however, these proteins become misfolded and form accumulations, known as neurofibrillary tangles, around the neuron’s nucleus. As these tau aggregates form, they interfere with the ability of a neuron to transport and process signals. The neurons are effectively ‘clogged up’, and eventually die. As this process continues throughout the brain, it has debilitating effects on cognitive and physical abilities. Due to the complexity of the disease, quality of care is often an issue in tauopathies. Diagnosis can be difficult, since the symptoms of tauopathy diseases can vary from person to person. Furthermore, the development of treatments has been hindered by the difficulty in studying tau accumulation in living brains. There are also ethical concerns in experiments that involve the study of tau pathology in live cells, since the process of accumulation can be slow, making results hard to observe over a viable timescale. Despite these constraints, researchers have made progress in the understanding and treatment of tauopathies, including the development of monoclonal antibodies and other therapies. In conclusion, tauopathies are a group of neurological diseases caused by the misfolding of tau proteins, which disrupt signal transmission and cause neuron death. Current treatments are mainly palliative, and further research is needed to develop effective diagnostic and treatment methods.
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : The role of beliefs, perception, and behavioural patterns in the evolution of psychophysical disorders
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : How have we eliminated infection: From the bone to brain?
Thomas J Webster, Interstellar Therapeutics, United States
Title : Cervical stenosis-induced chronic cerebrospinal fluid flow restriction as a contributing cause of dementia
Joe Sam Robinson, Mercer University, United States